![]()
PathHunter® Assay Principle (Panel A)
In this PathHunter® assay approach, a small peptide epitope (ProLink) is expressed
recombinantly on the intracellular C-terminus of the Receptor Tyrosine Kinase.
SH2 domains is co-expressed with a larger sequence, termed enzyme acceptor (EA).
Activation of receptor results in Dimerization and Phosphorylation of RTK with
subsequent interaction with SH2 protein. This interaction generates an active
β-galactosidase enzyme (complementation of β-gal fragments PK and EA),
which is detected using a chemiluminescent substrate (Panel A). The assays can be
run on 96-well, 384-well or 1536 well and read on standard plate luminometers.
![]()
Applications for the PathHunter® Cell-based Kinase technology
PathHunter® assay measures ligand binding, phosphorylation interaction with adaptor
proteins of receptor tyrosine kinases. Use of full length receptor protein allows identification
of anti-ligand, anti-receptor/Neutralizing and anti-dimerization antibodies (Panel B).
It is ideal for small molecule inhibitors as well (Panel C).
Copyright ©2012, DiscoveRx Corporation. TERMS AND CONDITIONS
0